Company Sichuan Biokin Pharmaceutical Co.,Ltd.

688506

CNE100006FN4

Pharmaceuticals

Analysts' Consensus

Business Summary

Share class

Sector

EPS Revisions

Annual profits - Rate of surprise

Sector Other Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 18:00:00 2024-06-25 EDT			5-day change	1st Jan Change
189.2 ^CNY	+0.94%		-3.82%	+35.25%

06-21	Sichuan Biokin Pharmaceutical Co.,Ltd. to Issue Shares and List in Hong Kong	CI
06-17	Sichuan Biokin Pharmaceutical Co.,Ltd.(SHSE:688506) added to Shanghai Stock Exchange Health Care Sector Index	CI

Sichuan Biokin Pharmaceutical Co Ltd is a China-based company mainly engaged in drug research and development, production and marketing. The Company is mainly engaged in two business sectors: chemical preparations and Chinese patent medicine preparations, and innovative biological medicine business. The Company's main products include propofol emulsion injection, dexmedetomidine hydrochloride injection, medium/long chain fat emulsion injection, ribavirin granules and other chemical preparations, Chaihuang granules and other Chinese patent medicine preparations. The Company mainly conducts its business in the domestic market.

Number of employees: 2,086

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	401,000,000	49,690,918 ( 12.39 %)	0	12.39 %

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

189.2 CNY

Average target price

226 CNY

Spread / Average Target

+19.44%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
SICHUAN BIOKIN PHARMACEUTICAL CO.,LTD.	+35.25%	10.35B
ELI LILLY AND COMPANY	+55.22%	815B
NOVO NORDISK A/S	+44.25%	654B
JOHNSON & JOHNSON	-6.34%	354B
MERCK & CO., INC.	+22.09%	337B
ABBVIE INC.	+10.85%	302B
ASTRAZENECA PLC	+18.45%	247B
ROCHE HOLDING AG	+2.09%	229B
NOVARTIS AG	+13.03%	219B
AMGEN INC.	+9.30%	171B

Other Pharmaceuticals